Bias as a source of inconsistency in ivermectin trials for COVID-19: A systematic review. Ivermectin's suggested benefits are mainly based on potentially biased results
偏倚是伊维菌素治疗新冠肺炎试验结果不一致的来源：一项系统评价。伊维菌素的潜在益处主要基于可能存在偏倚的结果。
期刊:Journal of Clinical Epidemiology
影响因子:5.2
doi:10.1016/j.jclinepi.2021.12.018
Izcovich, Ariel; Peiris, Sasha; Ragusa, Martín; Tortosa, Fernando; Rada, Gabriel; Aldighieri, Sylvain; Reveiz, Ludovic
